Home

arrow iconArticlesarrow iconarrow icon

Understanding Ovarian Reserve Testing For Women

Understanding Ovarian Reserve Testing For Women

Ovarian reserve testing assesses how many eggs remain in your ovaries and your fertility potential. Learn about AMH, FSH, and antral follicle count tests, what results mean, and how this information guides fertility decisions and treatment planning.

By FertilityIn

11 Dec 2025

7 min read

Ovarian Reserve Testing

Ovarian Reserve Testing

Ovarian reserve testing is a fundamental part of fertility evaluation that helps you and your doctor understand your reproductive health. These tests measure how many eggs remain in your ovaries and assess the quality of your egg supply, which directly impacts your ability to conceive naturally or through fertility treatments like IVF. Whether you're planning your family or concerned about your fertility timeline, understanding ovarian reserve testing empowers you to make informed decisions about your reproductive future.


What Is Ovarian Reserve and Why Does It Matter?

Ovarian reserve refers to the total number of eggs (oocytes) remaining in your ovaries at any given time. Unlike men, who produce new sperm throughout their lives, women are born with a fixed number of eggs approximately 1–2 million at birth. This number naturally declines with age, and by the time you reach your reproductive years, you have roughly 300,000–400,000 eggs. As you age, this number continues to decrease, and equally important, the quality of your remaining eggs may decline.


Understanding your ovarian reserve helps fertility specialists and gynecologists determine whether you have sufficient eggs for natural conception, plan the timing of family-building, or decide if fertility preservation options like egg freezing are right for you. For those pursuing assisted reproductive technology (ART) procedures, ovarian reserve testing guides medication dosing and helps predict how your ovaries will respond to stimulation.



Ovarian reserve testing involves three primary assessments, each providing unique insights into your fertility. Here's what to expect during the process:


Step 1: The AMH Blood Test (Anytime During Your Cycle)

The Anti-Müllerian Hormone (AMH) test is a simple blood test that measures the level of AMH protein produced by cells surrounding your developing eggs. This is one of the most reliable markers of ovarian reserve.


  • What to expect: A healthcare professional will draw a small blood sample from a vein in your arm, a quick procedure that takes less than five minutes. The best part? You can take this test at any time during your menstrual cycle, without special preparation. Unlike other fertility hormones that fluctuate throughout the month, AMH remains relatively consistent, making it an ideal screening test.
  • How results are interpreted: Your AMH level reflects the size of your egg pool. Higher levels generally indicate more eggs available, while lower levels suggest fewer eggs remain in reserve. However, AMH doesn't measure egg quality, only quantity.


Step 2: The Day 3 FSH Test (Early in Your Cycle)

Follicle-Stimulating Hormone (FSH) is a hormone your pituitary gland produces to signal your ovaries to develop and release eggs. Testing FSH early in your cycle reveals important information about your ovarian reserve.


  • What to expect: Schedule a blood draw on Day 2 or Day 3 of your menstrual cycle (Day 1 is the first day of bleeding). The timing matters because FSH levels are at their baseline at this point in your cycle. As with the AMH test, you'll have a simple blood draw with no special preparation needed.
  • How results are interpreted: Lower FSH levels on Day 3 indicate good ovarian reserve, while elevated FSH suggests your body is working harder to stimulate egg development, a sign of diminished reserve. FSH levels vary by laboratory, so your doctor will compare your results to the reference ranges used by your specific lab.


Step 3: Antral Follicle Count (AFC) via Transvaginal Ultrasound (Days 2–3)

The antral follicle count uses ultrasound imaging to visualize and count the small follicles in your ovaries that contain developing eggs. This test provides a direct visual assessment of your egg supply.


  • What to expect: This procedure is performed during the early follicular phase of your cycle, ideally on Day 2 or Day 3. You'll lie on an examination table and a trained technician will gently insert a thin ultrasound probe (about the thickness of a finger) into your vagina. The probe emits harmless sound waves that create detailed images of your ovaries on a monitor. The procedure is quick, usually lasting 15–30 minutes, and is generally not painful, though some women may experience mild discomfort during the probe insertion.
  • How results are interpreted: The technician carefully counts all visible follicles measuring 2–10 millimeters in diameter in each ovary. A normal antral follicle count ranges from 5 to 15 follicles per ovary. Counts below 5 suggest reduced ovarian reserve, while counts above 15 indicate higher reserve.


Understanding Your Ovarian Reserve Testing Results

Interpreting your results requires considering all three tests together, along with your age and medical history. Results from ovarian reserve testing don't predict whether you'll get pregnant naturally they predict how your ovaries will respond to fertility medications and stimulation.


AMH levels vary significantly by age. In general:

  • Under age 25: 4.1–6.8 ng/mL indicates very high ovarian reserve
  • Ages 25–30: 2.9–5.8 ng/mL indicates high ovarian reserve
  • Ages 31–35: 1.5–4.0 ng/mL indicates normal ovarian reserve
  • Ages 36–40: 0.5–1.5 ng/mL indicates reduced ovarian reserve
  • Over age 40: Below 0.5 ng/mL indicates low ovarian reserve


An AMH level of 1.0–3.5 ng/mL is considered optimal for fertility treatment response. Values below 0.5 ng/mL suggest significantly diminished ovarian reserve, while values above 4.0 ng/mL in younger women may indicate a higher response to ovarian stimulation medications.



Day 3 FSH levels are interpreted as follows:

  • Less than 9 mIU/mL: Normal FSH level with good expected response to ovarian stimulation
  • 9–11 mIU/mL: Fair FSH level with variable response to stimulation
  • 11–25 mIU/mL: Elevated FSH suggesting reduced ovarian reserve
  • Over 25 mIU/mL: Very elevated FSH indicating significantly diminished ovarian reserve

It's important to note that a normal FSH level doesn't completely rule out diminished ovarian reserve. If your FSH is normal but your estradiol (E2) level is elevated (above 60–80 pg/mL), your estradiol may be artificially "suppressing" your FSH, masking a reduced reserve.


Antral Follicle Count Results Explained

AFC results are interpreted by counting follicles in both ovaries:

  • 15–30 follicles total: Good ovarian reserve
  • 12–25 follicles total: Normal ovarian reserve
  • 8–15 follicles total: Adequate ovarian reserve
  • Below 8 follicles total: Reduced ovarian reserve suggesting diminished reserve


What If Your Results Show Diminished Ovarian Reserve?

A diagnosis of diminished ovarian reserve (DOR) means you have fewer eggs than expected for your age. While this finding may feel concerning, it's important to understand what it does and doesn't mean.


What diminished ovarian reserve does NOT mean:

  • You cannot get pregnant naturally many people with low ovarian reserve conceive without medical intervention
  • You should immediately pursue fertility treatment
  • Your eggs are of poor quality (ovarian reserve testing measures only quantity, not quality)
  • Fertility treatment will not work for you


What diminished ovarian reserve means:

  • You may have a shorter window for family planning
  • Fertility treatment may benefit you if you're trying to conceive
  • Your doctor may recommend higher doses of fertility medications
  • Egg preservation through egg freezing might be worth considering
  • Additional testing may help clarify your fertility situation

Even with very low AMH levels or significantly reduced antral follicle counts, pregnancy is possible. Your fertility specialist can discuss personalized treatment options tailored to your specific situation.


When Should You Consider Ovarian Reserve Testing?

Ovarian reserve testing is recommended if:

  • You're over age 35 and planning to conceive within the next year
  • You have a family history of early menopause
  • You have irregular or absent menstrual periods
  • You've experienced unexplained infertility
  • You're considering egg freezing or fertility preservation
  • You have a medical history of cancer treatment, endometriosis, or ovarian surgery
  • You want baseline information about your fertility timeline before pursuing pregnancy
  • You're planning fertility treatment like IVF or intrauterine insemination (IUI)


Key Takeaways About Ovarian Reserve Testing

Ovarian reserve testing provides essential information to guide your fertility decisions. AMH blood testing, Day 3 FSH measurement, and antral follicle count ultrasound together give your doctor a comprehensive picture of your egg supply and how your ovaries might respond to fertility treatment. While these tests cannot predict whether you'll become pregnant naturally or through treatment, they help your healthcare team personalize your care and set realistic expectations.


Remember that ovarian reserve testing is just one part of your complete fertility evaluation. Your age, medical history, partner's fertility status (if applicable), and overall health all factor into your fertility potential. If you receive results indicating diminished ovarian reserve, schedule a detailed consultation with a fertility specialist to discuss your options and create a plan that aligns with your family-building goals.


DISCLAIMER: This content is for educational purposes only and not a substitute for professional medical advice, diagnosis, or treatment. Ovarian reserve results vary by individual, age, medical history, and lab standards. Always consult a qualified fertility specialist or gynecologist for accurate evaluation and guidance.

18 views

Share

FertilityIn

Send Enquiry for this Story

Related Articles

Key Milestones in the Development of Assisted Reproductive Technology (ART)

Key Milestones in the Development of Assisted Reproductive Technology (ART)

The significant developments in Assisted Reproductive Technology (ART) throughout history, highlighting milestones from the first artificial insemination to modern techniques like In Vitro Fertilization (IVF) and genetic screening. These developments in ART have transformed fertility treatments, offering hope to individuals and couples facing infertility challenges.

ART

1 min read

Smart Ovulation Tools Driving New-Age Fertility Care for Precision, Confidence, and Continuit

Smart Ovulation Tools Driving New-Age Fertility Care for Precision, Confidence, and Continuit

Smart ovulation tools are redefining modern fertility care through connected sensors, AI-driven insights, and personalized data tracking. By merging convenience with clinical reliability, these innovations empower users and professionals alike, bridging home monitoring with informed decision-making for more precise, confident, and outcome-focused reproductive care.

ART

1 min read

Can Same-Sex Couples Have Children Through IVF or IUI?

Can Same-Sex Couples Have Children Through IVF or IUI?

How same-sex couples can achieve parenthood through assisted reproductive technology (ART), including IUI and IVF. It discusses the options available for lesbian couples, such as reciprocal IVF, and for gay male couples using surrogacy. The article also addresses legal challenges, success rates, and the future of family-building for LGBTQ+ couples

ART

1 min read

The Rise of Genetic Testing in Assisted Reproductive Technology (ART): Preimplantation Genetic Testing (PGT), PGD, and PGS

The Rise of Genetic Testing in Assisted Reproductive Technology (ART): Preimplantation Genetic Testing (PGT), PGD, and PGS

The significance of Preimplantation Genetic Testing in Assisted Reproductive Technology (ART), highlighting its role in selecting embryos free from genetic disorders. It details the methods of Preimplantation Genetic Testing, including PGD and PGS, and their impact on improving pregnancy success rates and reducing risks for couples.

ART

1 min read

Technology Mimicking Natural Sperm Selection to Identify High-Quality Sperm

Technology Mimicking Natural Sperm Selection to Identify High-Quality Sperm

Innovative technologies that replicate natural sperm selection processes to identify high-quality sperm for assisted reproductive techniques like IVF and ICSI. It highlights the use of biomimetic microfluidics, which filters sperm based on motility, and the integration of artificial intelligence for precise sperm quality assessment.

ART

1 min read

History of Sperm Donation & Egg Freezing in ART

History of Sperm Donation & Egg Freezing in ART

The evolution of sperm donation and egg freezing, from early artificial insemination to cutting-edge fertility solutions. As reproductive technology advances and societal values shift, these techniques are reshaping the future of parenthood. But what’s driving this growing demand?

ART

1 min read

The First Sperm Bank & Its Impact on ART History

The First Sperm Bank & Its Impact on ART History

The impact of the First Sperm Bank, established by Dr. John Rock in 1947, on Assisted Reproductive Technology (ART). It details how the First Sperm Bank revolutionized sperm donation, improved standards in fertility treatments like IUI and IVF, and provided new family-building opportunities for individuals and couples facing infertility challenges.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address